Events

Join the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center and Silent Spring Institute for a one-day CME event on the state of the science of environmental carcinogenesis and the role physicians, nurses, and healthcare providers play in reducing risk from exposure to environmental chemicals. Panel 1: What We Know about Environmental Exposures and Obstetrics & Gynecology and Pediatrics A review of evidence of environmental exposures with a focus on epidemiologic research of endocrine disrupting chemicals and their impact across the lifecourse. Panel 2 | What We Know about Environmental Exposures and Primary Care & Internal Medicine Exploring approaches for addressing exposure to common carcinogens like air pollution and metals and how physicians can play a role in reducing patient exposures. Panel 3 | How Cancer Care Providers Can Address Patient Concerns This panel will focus on how providers can address patient concerns with accurate information and guide discussions about risk reduction, survivorship and long term health. This activity has been approved for AMA PRA Category 1 CreditTM Register Now

This training session will cover: Opioid overview  What an opioid overdose is  Signs and symptoms of an opioid overdose  What increases the risk of opioid overdose  Medication for opioid use disorders  What naloxone is and how it works  Naloxone kit: components and use  Response steps for a suspected overdose  How to administer naloxone  How to use Fentanyl Test Strips Distribution of naloxone and Fentanyl test strips kits Fentanyl test strip and naloxone trainings are currently offered in-person to all members of the Columbia community, including Barnard College, Teachers College, Union Theological Seminary, Jewish Theological Seminary, and Columbia University Irving Medical Center. Attendees will be able to take a fentanyl test strip and naloxone kit or a naloxone kit only. *Columbia Health is a Registered Opioid Overdose Prevention Program, recognized by New York City and State Departments of Health. This designation came as part of a collaboration with researchers from the Mailman School of Public Health and the School of General Studies. Learn more about our Opioid Education and Naloxone Training program on our website.  Columbia University makes every effort to accommodate individuals with disabilities. If you require closed captioning, sign-language interpretation, or any other accommodation, please contact Disability Services at (212) 854-2388 or disability@columbia.edu at least 10 days in advance.

WELCOME TO THE ROBERT N. BUTLER COLUMBIA AGING CENTER VIRTUAL SERIES | AI + HEALTHY LONGEVITY Click here for full listing of the Columbia Aging Center "AI + Healthy Longevity" Seminar Series Our current series is dedicated to "AI + Healthy Longevity." The rise of artificial intelligence is set to transform health research, offering unprecedented opportunities for innovation, accuracy, and efficiency. As AI becomes more deeply integrated into research and healthcare, its applications hold the power to unlock new ways of improving health outcomes across the life course – particularly in later life. From predicting risks to preventing disease and preserving function, the use of AI to promote healthy longevity is only just beginning.  Yet alongside these opportunities come important challenges: ensuring data quality, promoting transparency, and addressing ethical concerns.  The Columbia Aging Center’s 2025–2026 virtual seminar series, AI + Healthy Longevity, will spotlight these critical issues. Through cutting-edge talks by leading experts – from population health to medical sciences –this series will explore how AI is shaping the future of aging research and advancing the quest for healthier, longer lives. Join us ONLINE on November 20 at noon, for the next in a series focusing on the applications of AI in aging. Details and registration link below. THURSDAY, NOVEMBER 20, 2025, 12:00-1:00 PM ET TITLE: AI Powered Therapeutics Discovery for Neurodegenerative Conditions Jianying Hu, PhD Director, HCLS Research Global Science Leader, AI for Healthcare IBM Research VIA ZOOM | REGISTER HERE: https://tinyurl.com/CACNov20    

“Benefits and risks of sustained suppression of VEGF-A for retinal/choroidal vascular diseases”   Peter Campochiaro, MD George S. and Dolores Dore Eccles Professor of Ophthalmology and Neuroscience Director, Retinal Cell and Molecular Laboratory Johns Hopkins School of Medicine